Prot #POL7080-011: A Multicenter, Open-Label, Randomized, Active-Controlled, Parallel Group, Pivotal Study to Investigate the Efficacy, Safety and Tolerability, and Pharmacokinetics of Murepavadin Combined with One Anti-Pseudomonal Antibiotic Versus Two A

Project: Research project

Project Details

StatusFinished
Effective start/end date4/5/18 → 4/5/21

Funding

  • Covance Inc. (Prot #POL7080-011 // Prot #POL7080-011)
  • Polyphor Ltd. (Prot #POL7080-011 // Prot #POL7080-011)